Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The basal energy expenditure of 10 Type 1 (insulin-dependent) C-peptide-negative diabetic patients (2042 +/- 62 kcal/24 h) was found to be significantly higher than the 1774 +/- 52 kcal/24 h predicted from their age, sex and body surface area (p less than 0.01). Intravenous insulin treatment significantly reduced energy expenditure to 1728 +/- 19 kcal/24h (p less than 0.01), which matched predicted values. The observed increase in metabolic rate in uncontrolled diabetic patients is associated with increased protein turnover, increased plasma glucagon, but no significant increase in cortisol, growth hormone or triiodothyronine concentrations in plasma. It may be accounted for by the energy cost of protein synthesis, or gluconeogenesis, or possibly increased sympathetic activity. This increased energy expenditure will contribute to the weight loss seen in Type 1 diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various rodent models of T1D display impairments in kidney mitochondrial functions, such as increased basal membrane expenditure; these were also elevated in comparison with predicted energy values for non-T1D people of similar age and body composition (4, 49).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [4]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, many other insulindependent cellular processes involving energy storage, including glycogen synthesis and lipogenesis, are reduced during insulin deficiency and thus reduce ATP demand (4)”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“well-documented upregulation of whole-body oxygen consumption in T1D and T2D indicates higher resting energy expenditure in untreated individuals (3)(4)(5)(6).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [4]
In the citing paper
“Glucagon promotes gluconeogenesis (4) and increased protein turnover (34,51), both ATP-dependent processes.”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Effect of poor diabetic control and obesity on whole body protein metabolism in man
Nair, K. S., Garrow, J. S., Ford, C., Mahler, R. F., & Halliday, D. (1983) · Diabetologia · doi:10.1007/bf00282518 · Cited by 196
Self-citationRavussin, E., Bogardus, C., Schwartz, R. S., Robbins, D. C., Wolfe, R. R., Horton, E. S., Danforth, E., & Sims, E. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111060 · Cited by 172
Glucose-induced Thermogenesis in Nondiabetic and Diabetic Obese Subjects
Golay, A., Schutz, Y., Meyer, H. U., Thiébaud, D., Curchod, B., Maeder, E., Felber, J.-P., & Jéquier, E. (1982) · Diabetes · doi:10.2337/diacare.31.11.1023 · Cited by 160
Thermic Response to Isoenergetic Protein, Carbohydrate or Fat Meals in Lean and Obese Subjects
Nair, K. S., Halliday, D., & Garrow, J. S. (1983) · Clinical Science · doi:10.1042/cs0650307 · Cited by 134
Self-citationROLE OF GLUCAGON AND OTHER HORMONES IN DEVELOPMENT OF DIABETIC KETOACIDOSIS
Alberti, K. G. M. M., Christensen, N. J., Iversen, J., & Ørskov, H. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92315-6 · Cited by 113
The role of amino acid oxidation in causing ‘specific dynamic action’ in man
Garrow, J. S., & Hawes, S. F. (1972) · British Journal of Nutrition · doi:10.1079/bjn19720084 · Cited by 93
Self-citationRELATIVE ENERGY REQUIREMENTS FOR MAINTENANCE, GROWTH, AND PHYSICAL ACTIVITY
Payne, P., & Waterlow, J. C. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90917-2 · Cited by 86
The Effect of Glucagon on the Metabolic Rate of Rats
Davidson, I. W. F., Salter, J., & BEST, C. H. (1960) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/8.5.540 · Cited by 70
Metabolism in diabetes mellitus
Benedict, F. G., & Joslin, E. P. (1910) · Carnegie Institution of Washington eBooks · doi:10.5962/t.174874 · Cited by 35
Metabolism in Diabetes Mellitus 1
MACDONALD, J. S. (1911) · Nature · doi:10.1038/085455b0 · Cited by 5
Lusk, G. (1911) · Science · doi:10.1126/science.33.846.433 · Cited by 4
Research works printed but not linked: 2
- Christofides ND (1982) Pancreatic glucagon. In: Bloom SR, Ling RG (eds) Radioimmunoassay of gut regulatory peptides. WB Saunders, London, pp 74-79
- Nair KS, Garrow JS (1984) Increased basal energy expenditure and reduced thermic response in diabetic patients, In: Hordon E, Forth D (eds) Proceedings of Fourth International Congress on Obesity -Satellite meeting on Regulation of Energy Expenditure John Libbey, London (in press)
Cited by
Temporal patterns in overweight and obesity in type 1 diabetes
Conway, B., Miller, R. G., Costacou, T., Fried, L., Kelsey, S., Evans, R. W., & Orchard, T. J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02956.x · Cited by 326
Pathogenesis of diabetic microangiopathy. The hemodynamic view
Zatz, R., & Brenner, B. M. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90719-9 · Cited by 320
Kelley, D. E., Bray, G. A., Pi-Sunyer, F. X., Klein, S., Hill, J., Miles, J., & Hollander, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1033 · Cited by 314
“Weight gain associated with treatment of type 2 diabetes with insulin and most oral hypoglycemic medications is in part explained by reductions in urinary energy (glucose) losses and by decreased energy expenditure due to lowering the rate of gluconeogenesis (21,22).”
BackgroundManini, T. M. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2009.08.002 · Cited by 280
Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes
Lanza, I. R., Zhang, S., Ward, L. E., Karakelides, H., Raftery, D., & Nair, K. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010538 · Cited by 266
“Second, insulin regulates protein synthesis and breakdown [8,9,10,11].”
BackgroundSelf-citation
Metadata
- Authors
- Nair, K. S., Halliday, D., & Garrow, J. S.
- Affiliations
- Northwick Park Hospital (GB)
- ORCID
- Nair, K.S.
- Venue
- Diabetologia
- Published
- 1984-07
- Volume
- 27
- Issue
- 1
- Pages
- 13-6
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2025505654
- Cited by
- 122
- References
- 12
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 5 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 3
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, basal energy expenditure, metabolic rate, uncontrolled diabetes, intravenous insulin, protein turnover, glucagon, weight loss, gluconeogenesis, sympathetic activity
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Energy Metabolism, Female, Glucagon, Humans, Hydrocortisone, Insulin, Male, Somatostatin, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.